During the past decade, Oncology Hematology Group of South Florida conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Hematology Group of South Florida" #1 sponsor was "Abbott" with 5 trials, followed by "Novartis" with 3 trials sponsored, "Novartis Pharmaceuticals" with 3 trials sponsored, "Sanofi" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Group of South Florida" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Smith Kline Beecham" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Hematology Group of South Florida" are "Colorectal Cancer" (3 trials), "Lung Cancer" (3 trials), "Breast Cancer" (2 trials), "Colonic Neoplasms" (2 trials) and "Colorectal Neoplasms" (2 trials). Many other conditions were trialed in "Oncology Hematology Group of South Florida" in a lesser frequency.

Most popular intervention types in "Oncology Hematology Group of South Florida" are "Drug" (22 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABT-751" (3 trials), "oxaliplatin" (3 trials), "FOLFOX regimen" (2 trials), "Vatalanib" (2 trials) and "fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Hematology Group of South Florida" are 19 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Oncology Hematology Group of South Florida". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Oncology Hematology Group of South Florida, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Hematology Group of South Florida, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".